Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Redefining the Burden of Intradialytic Hypotension in the Modern Era of Hemodialysis.

Van Buren PN.

Am J Nephrol. 2019;49(6):494-496. doi: 10.1159/000500878. Epub 2019 May 23. No abstract available.

2.

Relative blood volume monitoring in hemodialysis patients: identifying its appropriate role.

Van Buren PN.

Nephrol Dial Transplant. 2019 Aug 1;34(8):1251-1253. doi: 10.1093/ndt/gfy368. No abstract available.

PMID:
30590685
3.

SciApps: a cloud-based platform for reproducible bioinformatics workflows.

Wang L, Lu Z, Van Buren P, Ware D.

Bioinformatics. 2018 Nov 15;34(22):3917-3920. doi: 10.1093/bioinformatics/bty439.

4.

Assessing Extracellular Volume in Hemodialysis Patients Using Intradialytic Blood Pressure Slopes.

Liu H, Lu R, Shastri S, Sonderman M, Van Buren PN.

Nephron. 2018;139(2):120-130. doi: 10.1159/000487093. Epub 2018 Feb 13.

5.

Special situations: Intradialytic hypertension/chronic hypertension and intradialytic hypotension.

Van Buren PN, Inrig JK.

Semin Dial. 2017 Nov;30(6):545-552. doi: 10.1111/sdi.12631. Epub 2017 Jun 30. Review.

6.

Effect of Oral Iron Repletion on Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction and Iron Deficiency: The IRONOUT HF Randomized Clinical Trial.

Lewis GD, Malhotra R, Hernandez AF, McNulty SE, Smith A, Felker GM, Tang WHW, LaRue SJ, Redfield MM, Semigran MJ, Givertz MM, Van Buren P, Whellan D, Anstrom KJ, Shah MR, Desvigne-Nickens P, Butler J, Braunwald E; NHLBI Heart Failure Clinical Research Network.

JAMA. 2017 May 16;317(19):1958-1966. doi: 10.1001/jama.2017.5427. Erratum in: JAMA. 2017 Jun 20;317(23 ):2453.

7.

A Case of Severe Neutropenia From Short-Term Exposure to Moxifloxacin.

Chen W, Van Buren PN.

J Investig Med High Impact Case Rep. 2017 Mar 28;5(1):2324709617700648. doi: 10.1177/2324709617700648. eCollection 2017 Jan-Mar.

8.

Pathophysiology and implications of intradialytic hypertension.

Van Buren PN.

Curr Opin Nephrol Hypertens. 2017 Jul;26(4):303-310. doi: 10.1097/MNH.0000000000000334. Review.

9.

Extracellular Volume Overload and Increased Vasoconstriction in Patients With Recurrent Intradialytic Hypertension.

Van Buren PN, Zhou Y, Neyra JA, Xiao G, Vongpatanasin W, Inrig J, Toto R.

Kidney Blood Press Res. 2016;41(6):802-814. doi: 10.1159/000450565. Epub 2016 Nov 11.

10.

Evaluation and Treatment of Hypertension in End-Stage Renal Disease Patients on Hemodialysis.

Van Buren PN.

Curr Cardiol Rep. 2016 Dec;18(12):125. Review.

PMID:
27796862
11.

Comparison of Ambulatory Blood Pressure Patterns in Patients With Intradialytic Hypertension and Hemodialysis Controls.

Hompesch C, Ma TW, Neyra JA, Ripley L, Xiao G, Inrig J, Toto R, Van Buren PN.

Kidney Blood Press Res. 2016;41(3):240-9. doi: 10.1159/000443427. Epub 2016 Apr 22.

12.

Chronic kidney disease, cerebral blood flow, and white matter volume in hypertensive adults.

Tamura MK, Pajewski NM, Bryan RN, Weiner DE, Diamond M, Van Buren P, Taylor A, Beddhu S, Rosendorff C, Jahanian H, Zaharchuk G; SPRINT Study Research Group.

Neurology. 2016 Mar 29;86(13):1208-16. doi: 10.1212/WNL.0000000000002527. Epub 2016 Feb 26.

13.

Mechanisms and Treatment of Intradialytic Hypertension.

Van Buren PN, Inrig JK.

Blood Purif. 2016;41(1-3):188-93. doi: 10.1159/000441313. Epub 2016 Jan 15. Review.

14.

Determining the Feasibility of Spinal Cord Neuromodulation for the Treatment of Chronic Systolic Heart Failure: The DEFEAT-HF Study.

Zipes DP, Neuzil P, Theres H, Caraway D, Mann DL, Mannheimer C, Van Buren P, Linde C, Linderoth B, Kueffer F, Sarazin SA, DeJongste MJL; DEFEAT-HF Trial Investigators.

JACC Heart Fail. 2016 Feb;4(2):129-136. doi: 10.1016/j.jchf.2015.10.006. Epub 2015 Dec 9. Erratum in: JACC Heart Fail. 2018 Jun;6(6):542.

15.

Baseline characteristics of African Americans in the Systolic Blood Pressure Intervention Trial.

Still CH, Craven TE, Freedman BI, Van Buren PN, Sink KM, Killeen AA, Bates JT, Bee A, Contreras G, Oparil S, Pedley CM, Wall BM, White S, Woods DM, Rodriguez CJ, Wright JT Jr; SPRINT Study Research Group.

J Am Soc Hypertens. 2015 Sep;9(9):670-9. doi: 10.1016/j.jash.2015.06.012. Epub 2015 Aug 7.

16.

Sharing the care of mechanical circulatory support: collaborative efforts of patients/caregivers, shared-care sites, and left ventricular assist device implanting centers.

Kiernan MS, Joseph SM, Katz JN, Kilic A, Rich JD, Tallman MP, Van Buren P, Lyons JJ, Bethea B, Eckman P, Gosev I, Lee SS, Soleimani B, Takayama H, Patel CB, Uriel N; Evolving Mechanical Support Research Group (EMERG) Investigators.

Circ Heart Fail. 2015 May;8(3):629-35. doi: 10.1161/CIRCHEARTFAILURE.114.001767. No abstract available.

PMID:
25991805
17.

The Phosphate Binder Ferric Citrate and Mineral Metabolism and Inflammatory Markers in Maintenance Dialysis Patients: Results From Prespecified Analyses of a Randomized Clinical Trial.

Van Buren PN, Lewis JB, Dwyer JP, Greene T, Middleton J, Sika M, Umanath K, Abraham JD, Arfeen SS, Bowline IG, Chernin G, Fadem SZ, Goral S, Koury M, Sinsakul MV, Weiner DE; Collaborative Study Group.

Am J Kidney Dis. 2015 Sep;66(3):479-88. doi: 10.1053/j.ajkd.2015.03.013. Epub 2015 May 7.

18.

Myocardial stiffness in patients with heart failure and a preserved ejection fraction: contributions of collagen and titin.

Zile MR, Baicu CF, Ikonomidis JS, Stroud RE, Nietert PJ, Bradshaw AD, Slater R, Palmer BM, Van Buren P, Meyer M, Redfield MM, Bull DA, Granzier HL, LeWinter MM.

Circulation. 2015 Apr 7;131(14):1247-59. doi: 10.1161/CIRCULATIONAHA.114.013215. Epub 2015 Jan 30.

19.

Effect of low versus high dialysate sodium concentration on blood pressure and endothelial-derived vasoregulators during hemodialysis: a randomized crossover study.

Inrig JK, Molina C, D'Silva K, Kim C, Van Buren P, Allen JD, Toto R.

Am J Kidney Dis. 2015 Mar;65(3):464-73. doi: 10.1053/j.ajkd.2014.10.021. Epub 2014 Dec 17.

PMID:
25530107
20.

Potassium handling with dual renin-angiotensin system inhibition in diabetic nephropathy.

Van Buren PN, Adams-Huet B, Nguyen M, Molina C, Toto RD.

Clin J Am Soc Nephrol. 2014 Feb;9(2):295-301. doi: 10.2215/CJN.07460713. Epub 2014 Jan 9.

21.

The pathogenesis and management of hypertension in diabetic kidney disease.

Van Buren PN, Toto RD.

Med Clin North Am. 2013 Jan;97(1):31-51. doi: 10.1016/j.mcna.2012.10.003. Epub 2012 Nov 27. Review.

PMID:
23290728
22.

Current update in the management of diabetic nephropathy.

Van Buren PN, Toto R.

Curr Diabetes Rev. 2013 Jan 1;9(1):62-77. Review.

PMID:
23167665
23.

The prevalence of persistent intradialytic hypertension in a hemodialysis population with extended follow-up.

Van Buren PN, Kim C, Toto RD, Inrig JK.

Int J Artif Organs. 2012 Dec;35(12):1031-8. doi: 10.5301/ijao.5000126.

PMID:
23065874
24.

Probing the mechanisms of intradialytic hypertension: a pilot study targeting endothelial cell dysfunction.

Inrig JK, Van Buren P, Kim C, Vongpatanasin W, Povsic TJ, Toto R.

Clin J Am Soc Nephrol. 2012 Aug;7(8):1300-9. doi: 10.2215/CJN.10010911. Epub 2012 Jun 14.

25.

New perspectives on blood pressure variability in hemodialysis patients.

Van Buren PN, Shastri S, Inrig JK.

Am J Kidney Dis. 2012 Mar;59(3):333-5. doi: 10.1053/j.ajkd.2012.01.003. No abstract available.

PMID:
22340909
26.

Interdialytic ambulatory blood pressure in patients with intradialytic hypertension.

Van Buren PN, Toto R, Inrig JK.

Curr Opin Nephrol Hypertens. 2012 Jan;21(1):15-23. doi: 10.1097/MNH.0b013e32834db3e4. Review.

27.

Intradialytic hypertension and its association with endothelial cell dysfunction.

Inrig JK, Van Buren P, Kim C, Vongpatanasin W, Povsic TJ, Toto RD.

Clin J Am Soc Nephrol. 2011 Aug;6(8):2016-24. doi: 10.2215/CJN.11351210. Epub 2011 Jul 14.

28.

Iron overdose: a contributor to adverse outcomes in randomized trials of anemia correction in CKD.

Van Buren P, Velez RL, Vaziri ND, Zhou XJ.

Int Urol Nephrol. 2012 Apr;44(2):499-507. doi: 10.1007/s11255-011-0028-5. Epub 2011 Jul 10. Review.

29.

Intradialytic hypertension and the association with interdialytic ambulatory blood pressure.

Van Buren PN, Kim C, Toto R, Inrig JK.

Clin J Am Soc Nephrol. 2011 Jul;6(7):1684-91. doi: 10.2215/CJN.11041210.

30.

Identification and management of albuminuria in the primary care setting.

Kuritzky L, Toto R, Van Buren P.

J Clin Hypertens (Greenwich). 2011 Jun;13(6):438-49. doi: 10.1111/j.1751-7176.2010.00424.x. Epub 2011 Feb 1. Review.

31.

Hypertension and hemodialysis: pathophysiology and outcomes in adult and pediatric populations.

Van Buren PN, Inrig JK.

Pediatr Nephrol. 2012 Mar;27(3):339-50. doi: 10.1007/s00467-011-1775-3. Epub 2011 Feb 1. Review.

32.

Hypertension in diabetic nephropathy: epidemiology, mechanisms, and management.

Van Buren PN, Toto R.

Adv Chronic Kidney Dis. 2011 Jan;18(1):28-41. doi: 10.1053/j.ackd.2010.10.003. Review.

33.

Effective antihypertensive strategies for high-risk patients with diabetic nephropathy.

Van Buren PN, Adams-Huet B, Toto RD.

J Investig Med. 2010 Dec;58(8):950-6. doi: 10.231/JIM.0b013e3181ff46a5.

34.

The B73 maize genome: complexity, diversity, and dynamics.

Schnable PS, Ware D, Fulton RS, Stein JC, Wei F, Pasternak S, Liang C, Zhang J, Fulton L, Graves TA, Minx P, Reily AD, Courtney L, Kruchowski SS, Tomlinson C, Strong C, Delehaunty K, Fronick C, Courtney B, Rock SM, Belter E, Du F, Kim K, Abbott RM, Cotton M, Levy A, Marchetto P, Ochoa K, Jackson SM, Gillam B, Chen W, Yan L, Higginbotham J, Cardenas M, Waligorski J, Applebaum E, Phelps L, Falcone J, Kanchi K, Thane T, Scimone A, Thane N, Henke J, Wang T, Ruppert J, Shah N, Rotter K, Hodges J, Ingenthron E, Cordes M, Kohlberg S, Sgro J, Delgado B, Mead K, Chinwalla A, Leonard S, Crouse K, Collura K, Kudrna D, Currie J, He R, Angelova A, Rajasekar S, Mueller T, Lomeli R, Scara G, Ko A, Delaney K, Wissotski M, Lopez G, Campos D, Braidotti M, Ashley E, Golser W, Kim H, Lee S, Lin J, Dujmic Z, Kim W, Talag J, Zuccolo A, Fan C, Sebastian A, Kramer M, Spiegel L, Nascimento L, Zutavern T, Miller B, Ambroise C, Muller S, Spooner W, Narechania A, Ren L, Wei S, Kumari S, Faga B, Levy MJ, McMahan L, Van Buren P, Vaughn MW, Ying K, Yeh CT, Emrich SJ, Jia Y, Kalyanaraman A, Hsia AP, Barbazuk WB, Baucom RS, Brutnell TP, Carpita NC, Chaparro C, Chia JM, Deragon JM, Estill JC, Fu Y, Jeddeloh JA, Han Y, Lee H, Li P, Lisch DR, Liu S, Liu Z, Nagel DH, McCann MC, SanMiguel P, Myers AM, Nettleton D, Nguyen J, Penning BW, Ponnala L, Schneider KL, Schwartz DC, Sharma A, Soderlund C, Springer NM, Sun Q, Wang H, Waterman M, Westerman R, Wolfgruber TK, Yang L, Yu Y, Zhang L, Zhou S, Zhu Q, Bennetzen JL, Dawe RK, Jiang J, Jiang N, Presting GG, Wessler SR, Aluru S, Martienssen RA, Clifton SW, McCombie WR, Wing RA, Wilson RK.

Science. 2009 Nov 20;326(5956):1112-5. doi: 10.1126/science.1178534. Erratum in: Science. 2012 Aug 31;337(6098):1040.

35.

Skeletal muscle myofibrillar protein metabolism in heart failure: relationship to immune activation and functional capacity.

Toth MJ, Matthews DE, Ades PA, Tischler MD, Van Buren P, Previs M, LeWinter MM.

Am J Physiol Endocrinol Metab. 2005 Apr;288(4):E685-92. Epub 2004 Nov 23.

36.

Using insulin pump therapy to achieve normoglycemia.

Van Buren PD.

JAAPA. 2003 Jul;16(7):33-6. No abstract available.

PMID:
14968497
37.

How many echocardiograms are necessary for follow-up evaluation of patients with Kawasaki disease?

McMorrow Tuohy AM, Tani LY, Cetta F, Lewin MB, Eidem BW, Van Buren P, Williams RV, Shaddy RE, Tuohy RP, Minich LL.

Am J Cardiol. 2001 Aug 1;88(3):328-30. No abstract available.

PMID:
11472722
38.

Outcome in patients with symptomatic occlusion of the internal carotid artery.

Klijn CJ, van Buren PA, Kappelle LJ, Tulleken CA, Eikelboom BC, Algra A, van Gijn J.

Eur J Vasc Endovasc Surg. 2000 Jun;19(6):579-86.

39.

The importance of revision of early restenosis after endovascular remote endarterectomy in SFA occlusive disease.

Ho GH, van Buren PA, Moll FL, van der Bom JG, Eikelboom BC.

Eur J Vasc Endovasc Surg. 2000 Jan;19(1):35-42.

40.
41.

Cholesterol pericarditis and cardiac tamponade with congenital hypothyroidism in adulthood.

Van Buren PC, Roberts WC.

Am Heart J. 1990 Mar;119(3 Pt 1):697-700. No abstract available.

PMID:
2309619

Supplemental Content

Loading ...
Support Center